EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study

Sheerien Kareem Rajput iD, Khurram Minhas, Iqbal Azam, Sadia Habib, Usman Shaikh, El-Nasir Lalani iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0320934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Sheerien Kareem Rajput und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Regenerative Medicine and Stem Cell Research, The Aga Khan University, Karachi, Pakistan. Hauptthemen laut MEDLINE: Mucin-1, X-Box Binding Protein 1, Multiple Myeloma, DNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) is a disease of malignant plasma cells (PC) with poor survival. Disease progression and treatment relapse are attributed to MM cancer stem cells (CSCs) and signaling molecules such as MUC1 and XBP1. The study aimed to determine the prognostic value of expression of CSC-associated biomarkers, MUC1 and XBP1 in MM, which has not been explored previously. In this study, we determined the immunohistochemical expression of CSC markers (ALDH1, CD117, and CD34), MUC1, and XBP1 in 128 MM formalin-fixed paraffin-embedded bone marrow archival blocks. The expression of biomarkers was assessed for association with clinicopathological variables and patient survival. Descriptive analysis, survival plots and crude association between outcome and independent variables were assessed using Kaplan Meier and Log rank test. Univariate and multivariable analyses were performed using simple and multiple Cox regression models. The results are reported as crude and adjusted hazard ratios with 95% confidence intervals. Expression of ALDH1 and CD117 was found in 51% and 48% of the tumors, respectively. ALDH1 expression was associated with 1.83 years of reduced survival for patients with CD56-negative tumors. MUC1 expression was observed in 62%, whereas XBP1 was expressed in 48% of tumors. Combinatorial group analysis of XBP1 and MUC1 stratified patients into two prognostic groups. Cases with tumors negative for expression of MUC1 and XBP1 (XBP1-/ MUC1-) were categorized as a good prognostic group with increased survival of 3.42 years compared to cases with tumors expressing both ( Worst prognosis , XBP1 + /MUC1+) . Concordant expression of MUC1 and XBP1 in MM defines a subset of patients with adverse outcomes. The adjusted hazard ratio showed a four-fold increased risk of mortality associated with the concordant expression of MUC1 and XBP1 in patients > 65 years of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1X-Box Binding Protein 1Multiple MyelomaDNA-Binding ProteinsTranscription FactorsHumansFemaleMalePrognosisMiddle AgedAgedRetrospective StudiesBiomarkers, TumorAdultAged, 80 and overRegulatory Factor X Transcription FactorsGene Expression Regulation, NeoplasticKaplan-Meier EstimateNeoplastic Stem Cells

Substanzen

Mucin-1X-Box Binding Protein 1XBP1 protein, humanMUC1 protein, humanBiomarkers, TumorRegulatory Factor X Transcription FactorsDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Centre for Regenerative Medicine and Stem Cell Research, The Aga Khan University, Karachi, Pakistan.
  • Department of Pathology and Laboratory Medicine, The Aga Khan University, Karachi, Pakistan.
  • Department of Community Health Sciences, The Aga Khan University, Karachi, Pakistan.

ORCID-Profile: Sheerien Kareem Rajput, El-Nasir Lalani

Zitieren

APA

Rajput, S. K., Minhas, K., Azam, I., Habib, S., Shaikh, U., & Lalani, E. N. (2025). Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study. PLOS ONE. https://doi.org/10.1371/journal.pone.0320934

Vancouver

Rajput SK, Minhas K, Azam I, Habib S, Shaikh U, Lalani EN. Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study. PLOS ONE. 2025. doi:10.1371/journal.pone.0320934

BibTeX
@article{Rajput2025,
  author = {Rajput, Sheerien Kareem and Minhas, Khurram and Azam, Iqbal and Habib, Sadia and Shaikh, Usman and Lalani, El-Nasir},
  title = {Prognostic implications of MUC1 and XBP1 concordant expression in multiple myeloma: A retrospective study},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0320934}
}
Kostenlos starten →